H. Baurmann

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Nicolaus Kröger, Ernst Holler, Guido Kobbe et al. · Blood · 2009 · 394 citations · Full text

Medicine, Hematology, Immunology +17

Reduced-intensity conditioning versus standard conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: a prospective, open-label randomised phase 3 trial

Martin Bornhäuser, Joachim Kienast, Rudolf Trenschel et al. · The Lancet Oncology · 2012 · 272 citations

Medicine, Hematology, Immunology +14

High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study Group.

W. Siegert, J. Beyer, Imke Strohscheer et al. · Journal of Clinical Oncology · 1994 · 226 citations

Pharmacy, Oncology, Pharmacotherapy +16

Autologous stem cell transplantation for progressive multiple sclerosis: Update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database

Riccardo Saccardi, Tomáš Kozák, Chiara Bocelli‐Tyndall et al. · Multiple Sclerosis Journal · 2006 · 217 citations

Medicine, Hematology, Immunology +16

Hematopoietic Stem-Cell Transplantation for Advanced Systemic Mastocytosis

Celalettin Üstün, Andreas Reiter, Bart L. Scott et al. · Journal of Clinical Oncology · 2014 · 185 citations · Full text

Medicine, Hematology, Immunology +17